Studies have shown that active fund managers routinely underperform the S&P500 index*​

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)

RXRX Stock Predictions and Ratings

WSX Rating: STRONG SELL
WSX Price Target (1yr): -36%
Consensus Rating: STRONG BUY
Consensus Price Target (1yr): 141%

RXRX Valuation

RXRX PS Ratio
Industry PS Ratio
S&P 500 PS Ratio

31.9
7.5
3.3

RXRX Growth Estimates

RXRX Revenue Forecast
Industry Revenue Forecast
S&P 500 Revenue Forecast

-32.7%
40.3%
11.9%

RXRX Frequently Asked Questions

Is RXRX stock a buy?

Wall Street X rates RXRX a STRONG SELL, and the average consensus rating is a STRONG BUY.

Wall Street X has a price target of $2.14 for RXRX, and the average consensus target is $8.05 .

To buy shares of RXRX, open an account with an online brokerage, deposit money from your bank, search for “RXRX”, choose the number of shares or dollar amount, and place a trade.

Recursion Pharmaceuticals combines biology, automation, and machine learning to discover and develop medicines. Its platform is used to identify drug candidates and therapeutic opportunities across multiple disease areas.

Popular Articles

This Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) page was last updated on September 4, 2026 by wallstreetx.com.

How Wall Street X Rates Stocks